Purification and characterization of human and mouse recombinant alpha-fetoproteins expressed in Escherichia coli

Protein Expression and Purification

Volumn 10, Issue 1, 1997, Pages 10-26

  Boismenu, Richard ^a   Semeniuk, Daniel ^a   Murgita, Robert A ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0031172412     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1006/prep.1996.0697     Document Type: Article

References (57)

1. Tilghman S. M. The structure and regulation of the αfetoprotein and albumin genes. Oxford Surveys on Eukaryotic Genes. 1985;Oxford Univ. Press, London. p. 160-206.
2. Brown J. R. Structural origins of mammalian albumin. Fed. Proc. 35:1976;2141-2144.
3. He M. H., Carter D. C. Atomic structure and chemistry of human serum albumin. Nature. 358:1992;209-215.
4. Deutsch H. F. Chemistry and biology of α-fetoprotein. Adv. Cancer Res. 56:1991;253-312.
5. Murgita R. A., Wigzell H. Regulation of immune factors in the fetus and newborn. Prog. Allergy. 29:1981;54-133.
6. van Oers N. S. C., Cohen B. L., Murgita R. A. Isolation and characterization of a distinct immunoregulatory isoform of α-fetoprotein produced by the normal fetus. J. Exp. Med. 170:1989;811-825.
7. Hoskin D. W., Hamel S., Hooper D. C., Murgita R. A. In vitro activation of bone marrow-derived T- and non-T-cell subsets by alpha-fetoprotein. Cell. Immunol. 96:1985;163-174.
8. Mizejewski G. J., Vonnegut M., Jacobson H. I. Estradiol activated α-fetoprotein suppresses the uterotrophic response to estrogens. Proc. Natl. Acad. Sci. USA. 80:1983;2733-2737.
9. Soto A. M., Sonnenschein C. Control of growth of estrogen-sensitive cells: Role for α-fetoprotein. Proc. Natl. Acad. Sci. USA. 4:1980;2084-2087.
10. Jacobson H. I., Bennett J. A., Mizejewski G. J. Inhibition of estrogen-dependent breast cancer growth by a reaction product of α-fetoprotein and estradiol. Cancer Res. 50:1990;415-420.
11. Nunez E. A. Biological role of alpha-fetoprotein in the endocrinological field: Data and hypotheses. Tumor Biol. 15:1994;63-72.
12. Nishi S., Koyama Y., Sakamoto T., Soda M., Kairiyama C. B. Expression of rat α-fetoprotein cDNA inEscherichia coli. J. Biochem. 104:1988;968-972.
13. Yamamoto R., Sakamoto T., Nishi S., Sakai M., Morinaga T., Tamaoki T. Expression of human α-fetoprotein in yeast. Life Sci. 46:1990;1679-1686.
14. Giuliani M. M., Ricci S., Ratti G., Pucci P., Mariano G., Malorni A., Ceccarini C., Terrana B., Tecce M. F. Synthesis and characterization of a recombinant fragment of human alpha-fetoprotein with antigenic selectivity versus albumin. Protein Eng. 2:1989;605-610.
15. Boismenu R., DuBow M. S., Murgita R. A. Expression of domains of mouse α-fetoprotein inEscherichia coli. Life Sci. 43:1988;673-681.
16. Olsen M. K., Rockenbach S. K., Curry K. A., Tomich C-S. C. Enhancement of heterologous polypeptide expression by alterations in the ribosome binding site sequence. J. Biotechnol. 9:1989;179-190.
17. Tilghman S. M., Kioussis D., Gorin M. B., Ruiz J. P. G., Ingram R. S. The presence of intervening sequences in the alpha-fetoprotein gene of the mouse. J. Biol. Chem. 254:1979;7393-7399.
18. Chirgwin J. M., Przybyla A. E., MacDonald R. J., Rutter N. J. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry. 18:1979;5294-5299.
19. Sambrook J., Fritsch E. F., Maniatis T. Molecular Cloning: A Laboratory Manual. 1989;Cold Spring Harbor Laboratory, Cold Spring Harbor.
20. Maxam A., Gilbert W. Sequencing end-labelled DNA with base-specific chemical cleavages. Methods Enzymol. 65:1980;499-560.
21. Southern E. M. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J. Mol. Biol. 98:1975;503-517.
22. Sanger F., Nicklen S., Coulson R. A. DNA sequencing with chain terminating inhibitors. Proc. Natl. Acad. Sci. USA. 74:1977;5463-5467.
23. Morinaga T., Masaharu S., Wegmann T. G., Tamaoki T. Primary structures of human α-fetoprotein and its mRNA. Proc. Natl. Acad. Sci. USA. 80:1983;4604-4608.
24. Rimm D. L., Pollard T. D. New plasmid vectors for high level synthesis of eukaryotic fusion proteins inEscherichia coli. Gene. 75:1989;323-327.
25. Guan C., Li P., Riggs P. D., Iouye H. Vectors that facilitate the expression and purification of foreign peptides inEscherichia coli. Gene. 67:1987;21-30.
26. Latta M., Knapp M., Samientos P., Breford G., Becquart J., Guerrier L., Jung G., Mayaux J. F. Synthesis and purification of mature human serum albumin fromE. coli. Bio/Technology. 5:1987;1309-1314.
27. Aoyagi Y., Ikenada T., Ichida F. Copper(II)-binding ability of human AFP. Cancer Res. 38:1978;3483-3486.
28. Hooper D. C., O'Neill G., Gronvik K.-O., Gold P., Murgita R. A. Human alpha-fetoprotein inhibits cell proliferation and NK-like cytotoxic activity in autologous but not in allogeneic mixed lymphocyte reactions. Mizejewski G. J., Jacobson J. Biological Activity of Alpha-Fetoprotein. 1989;183-197 CRC Press, Boca Raton.
29. Uhler M., Moks T. Gene fusions for purposes of expression: An introduction. Methods Enzymol. 185:1990;129-143.
30. Gorin M. B., Cooper D. L., Eiferman F., van de Rijn P., Tilghman S. M. The evolution of alpha-fetoprotein and albumin. I. A comparison of the primary amino acid sequences of mammalian alpha-fetoprotein and albumin. J. Biol. Chem. 256:1981;1954-1959.
31. Le H. V., Paul P. T. Purification of secreted recombinant proteins fromEscherichia coli. Seetharam R., Sharma S. K. Purification and Analysis of Recombinant Proteins. 1991;163-181 Marcel Dekker, New York.
32. Schein C. H. Solubility as a function of protein structure and solvent components. Bio/Technology. 8:1990;308-317.
33. Mitraki A., King J. Protein folding intermediates and inclusion body formation. Bio-Technology. 7:1989;690-697.
34. Ferranti P., Pucci P., Marino G., Fiume I., Terrana C., Ceccarini B., Malorni A. Human α-fetoprotein produced from Hep G2 cell line: Structure and heterogeneity of the oligosaccharide moiety. J. Mass. Spectrom. 30:1995;632-638.
35. Chakraborty M., Mandal C. Immuno-suppresssive effect of human alphafetoprotein: A cross species study. Immunol. Invest. 22:1993;329-339.
36. Studier F. W., Rosenberg A. H., Dunn J. J., Dubendorff J. W. Use of T7 RNA polymerase to direct expression of cloned genes. Methods Enzymol. 185:1990;113-130.
37. Tabor S. Expression using the T7 RNA polymerase/promoter system. Ausebel F. M., Brent R., Kingston R. E., Moore D. D., Seidman J. G., Smith J. A., Struhl K. Current Protocols in Molecular Biology. 1990;16.2.1-16.2.11 Green Publishing Associates, Toronto.
38. deBoer H. A., Hui A. S. Sequences within ribosome binding sites affecting messenger RNA translatability and method to direct ribosomes to single messenger RNA species. Methods Enzymol. 185:1991;103-114.
39. Lazdunski A. M. Peptidases and proteases ofEscherichia coliSalmonella typhimurium. FEMS Microbiol. Rev. 5:1989;265-276.
40. Goff S. A., Goldberg A. L. Production of abnormal proteins inE. coli. Cell. 41:1985;587-595.
41. Kohno T., Carmichael D. F., Sommer A., Thompson R. C. Refolding of recombinant proteins. Methods Enzymol. 185:1991;187-195.
42. Pohl G., Kallstrom M., Bergsdorf N., Wallen P., Jorvall H. Tissue plasminogen activator: Peptide analysis confirm an indirectly derived amino acid sequence, identify the active serine residue, establish glycosylation sites and localize variant differences. Biochemistry. 23:1984;3701-3707.
43. Harris T. J. R., Patel T., Marston F. A. O., Little S., Emtage S., Oppendakker G., Volkaert G., Rombauts W., Billiau A., De Somer P. Cloning of cDNA for human tPA and its expression inE. coli. Mol. Biol. Med. 3:1986;279-292.
44. Datar R. V., Cartwright T., Rosen C.-G. Process economics of animal cell and bacterial fermentations: A case study analysis of tissue plasminogen activator. Bio/Technology. 11:1993;349-357.
45. Andersen J. S., Svensson B., Roepstorff P. Electrospray ionization and matrix assisted laser desorption/ionization mass spectrometry: Powerful analytical tool in recombinant protein chemistry. Nature Biotechnol. 14:1996;440-457.
46. Sherman F., Stewart J. W., Tsunasawa S. Methionine or not methioninie at the beginning of a protein. Bioessays. 3:1985;27-31.
47. Pucci P., Siciliano R., Malorni A., Marino G., Tecce M. F., Ceccarini C., Terrana B. Human α-fetoprotein primary structure: A mass spectrometric study. Biochemistry. 30:1991;5061-5066.
48. Chan B., Dodsworth N., Woodrow J., Tucker T., Harris R. Site-specific N-terminal auto-degradation of human serum albumin. Eur. J. Biochem. 227:1995;524-528.
49. Wu J. T., Monir-Vaghefi S. M., Clayton F. Human alpha-fetoprotein and albumin: Differences in zinc binding. Clin. Physiol. Biochem. 5:1987;85-94.
50. D. J. Semeniuk, R. Boismenu, J. Tam, R. A. Murgita, 1995, Biological activities of recombinant alpha-fetoproteins, Proceedings of the 9th International Congress of Immunology, 863.
51. Semeniuk D. J., Murgita R. A. Alpha-fetoprotein immunoregulation is not associated with transforming growth factor-beta 2. Fed. Proc. 10:1996;A1442.
52. Bennett J. A., Semeniuk D. J., Jacobson H. I., Murgita R. A. Recombinant human alpha-fetoprotein is similar to the natural protein in its transformability to an inhibitor of estrogen-dependent breast cancer growth. Proc. Am. Assoc. Cancer Res. 36:1995;262.
53. Keller R. H., Calvanico N. J., Tomasi T. B. Jr. Immunosuppressive properties of AFP: Role of estrogens. Fishman W. H., Sell S. Onco Developmental Gene Expression. 1976;287-297 Academic Press, New York.
54. Khair-El-Din T. A., Sicher S. C., Vazquez M. A., Wright W. J., Lu C. Y. Docosahexaenoic acid, a major constituent of fetal serum and fish oil diets, inhibits IFNγ-induced Ia-expression by murine macrophages in vitro. J. Immunol. 154:1995;1296-1306.
55. 22. J. Exp. Med. 172:1990;1391-1401.
56. Bushman E., van Oers N. S. C., Katz M., Murgita R. A. Experimental myasthenia gravis induced in mice by passive transfer of human myasthenic immunoglobulin. Evidence for an ameliorating effect by alpha-fetoprotein. J. Neuroimmunol. 13:1987;315-330.
57. Ogata A., Yamashita T., Koyama Y., Sakai M., Nishi N. Suppression of experimental antigen-induced arthritis in transgenic mice producing human α-fetoprotein. Biochem. Biophys. Res. Commun. 213:1995;362-366.